Fri, Apr 23, 2021 • 8:30am - 3pm
This symposium will focus on the diagnosis and management of rheumatic conditions that are characterized by Rheumatoid Arthritis (RA). This will include presentations focused on Interstitial Lung Disease (ILD), preclinical RA including immune checkpoint inhibitors and lessons learned in RA, prevention and treatment of infections in immunosuppressed patients, and other rheumatic disorders. The symposium will use traditional didactic lectures from well-recognized national experts, as well as topical case presentations and open discussions.
This symposium is intended for physicians, physician assistants, nurse practitioners, nurses, residents, and fellows who care for patients with rheumatologic diseases, particularly rheumatoid arthritis.
At the conclusion of this symposium, the participant should be better able to:
- Identify key contributors to the pathogenesis of rheumatoid arthritis-associated interstitial lung disease (RA-ILD)
- Characterize RA-ILD clinical manifestations, detection, diagnosis, and natural history
- Discuss the potential role of available and emerging pharmaceutical modalities in the management of RA-ILD
- Summarize what is known regarding the epidemiology and outcomes of serious infections in RA patients and their relationship with disease-modifying treatments
- Describe approaches to predict and prevent serious infections occurring in the context of disease-modifying treatment
- Describe progress that has been made in the development of predictive markers for preclinical RA and insights provided from these advancements for future identification and early intervention for the disease
- Describe progress in the use of autoantibodies as biomarkers in patients with seronegative RA
- Describe recent advancements in immune checkpoint inhibitors both in application to RA and the ways in which they may exacerbate the disease process
Continuing Education Credits
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
5.25 Contact Hours Awarded
Nebraska Medicine is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This symposium is sponsored by the UNMC Department of Internal Medicine—Division of Rheumatology and Immunology, through the resources of Nebraska Medicine and the UNMC Center for Continuing Education.